Participants, n | 35 | 36 |
|
Age, years | 40.3 (12.3) | 40.3 (12.8) |
|
Sex, male/female | 15/20 | 17/19 |
|
Duration of asthma, years | 22.6 (14) | 23.1 (12) |
|
Daily dose of ICS prescribed, μga,b | 565 (254) | 611 (222) |
|
Daily dose of ICS used, μgb,c | 272 (185) | 283 (152) |
|
Adherence with ICS, %b | 45.4 (16.6) | 45.6 (17) |
|
Prednisolone courses, nb | 1.17 (1) | 1.0 (0.9) |
|
Canisters of short-acting β2-agonist, nb | 10.2 (5.3) | 12.4 (4.9) |
|
FEV1, litres | 2.65 (0.82) | 2.9 (0.84) |
|
FEV1 % predicted | 82.3 (18.7) | 88.1 (19.3) |
|
GP visits for asthma, nb | 2.4 (1.4) | 1.4 (1.1) |
|
Mini AQLQ score | 4.7 (0.9) | 4.9 (1.1) |
|
ACQ score | 2.11 (0.9) | 1.82 (0.8) |
|
Smokers (previous or current), n | 15 | 15 |
|
Pack-years among smokers | 9.5 (7) | 6.7 (5) |